TD Private Client Wealth LLC Sells 883 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

TD Private Client Wealth LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,344 shares of the healthcare conglomerate’s stock after selling 883 shares during the period. TD Private Client Wealth LLC’s holdings in UnitedHealth Group were worth $11,310,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. Delta Financial Group Inc. grew its position in UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares during the last quarter. Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares in the last quarter. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares in the last quarter. GoalVest Advisory LLC boosted its stake in UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after buying an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC raised its position in UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.8 %

UNH opened at $565.39 on Wednesday. The stock has a market cap of $520.31 billion, a PE ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock’s fifty day simple moving average is $586.36 and its 200 day simple moving average is $559.39.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.56 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent analyst reports. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $626.84.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.